BMJ Best Practice

参考文献

关键文献

American Academy of Ophthalmology. Preferred practice pattern: amblyopia. San Francisco, CA: American Academy of Ophthalmology; 2012.

Cotter SA, Edwards AR, Wallace DK, et al. Treatment of anisometropic amblyopia in children with refractive correction. Ophthalmology. 2006;113:895-903.

Wallace DK, Chandler DL, Beck RW, et al. Pediatric Eye Disease Investigator Group. Treatment of bilateral refractive amblyopia in children three to less than 10 years of age. Am J Ophthalmol. 2007;144:487-496.

Pediatric Eye Disease Investigator Group. A randomized trial of atropine vs. patching for treatment of moderate amblyopia in children. Arch Ophthalmol. 2002;120:268-278.

Repka MX, Beck RW, Holmes JM, et al. Pediatric Eye Disease Investigator Group. A randomized trial of patching regimens for treatment of moderate amblyopia in children. Arch Ophthalmol. 2003;121:603-611.

Wallace DK, Edwards AR, Cotter SA, et al. A randomized trial to evaluate 2 hours of daily patching for strabismic and anisometropic amblyopia in children. Ophthalmology. 2006;113:904-912.

Stewart CE, Stephens DA, Fielder AR, et al. Objectively monitored patching regimens for treatment of amblyopia: randomised trial. BMJ. 2007;335:707.

Holmes JM, Kraker RT, Beck RW, et al. Pediatric Eye Disease Investigator Group. A randomized trial of prescribed patching regimens for treatment of severe amblyopia in children. Ophthalmology. 2003;110:2075-2087.

Wallace DK, Lazar EL, Holmes JM, et al; Pediatric Eye Disease Investigator Group. A randomized trial of increasing patching for amblyopia. Ophthalmology. 2013;120:2270-2277.

参考文章

1.  American Academy of Ophthalmology. Preferred practice pattern: amblyopia. San Francisco, CA: American Academy of Ophthalmology; 2012.

2.  Wiesel TN, Hubel DH. Single-cell responses in striate cortex of kittens deprived of vision in one eye. J Neurophysiol. 1963;26:1003-1017.

3.  Hubel DH, Wiesel TN. The period of susceptibility to the physiological effects of unilateral eye closure in kittens. J Physiol. 1970;206:419-436.

4.  Ip JM, Robaei D, Rochtchina E, et al. Prevalence of eye disorders in young children with eyestrain complaints. Am J Ophthalmol. 2006;142:495-497.

5.  Multi-ethnic Pediatric Eye Disease Study Group. Prevalence of amblyopia and strabismus in African American and Hispanic children ages 6 to 72 months: the multi-ethnic pediatric eye disease study. Ophthalmology. 2008;115:1229-1236;e1.

6.  Attebo K, Mitchell P, Cumming R, et al. Prevalence and causes of amblyopia in an adult population. Ophthalmology. 1998;105:154-159.

7.  Shaw DE, Fielder AR, Minshull C, et al. Amblyopia: factors influencing age of presentation. Lancet. 1988;2:207-209.

8.  Preslan MW, Novak A. Baltimore Vision Screening Project. Ophthalmology. 1996;103:105-109.

9.  Nilsson J. The negative impact of amblyopia from a population perspective: untreated amblyopia almost doubles the lifetime risk of bilateral visual impairment. Br J Ophthalmol. 2007;91:1417-1418.

10.  Robaei D, Kifley A, Rose KA, et al. Impact of amblyopia on vision at age 12 years: findings from a population-based study. Eye. 2008;22:496-502.

11.  Williams C, Northstone K, Howard M, et al. Prevalence and risk factors for common vision problems in children: data from the ALSPAC study. Br J Ophthalmol. 2008;92:959-964.

12.  Lai YH, Hsu HT, Wang HZ, et al. The visual status of children ages 3 to 6 years in the vision screening program in Taiwan. J AAPOS. 2009;13:58-62.

13.  Drover JR, Kean PG, Courage ML, et al. Prevalence of amblyopia and other vision disorders in young Newfoundland and Labrador children. Can J Ophthalmol. 2008;43:89-94.

14.  Robaei D, Rose KA, Ojaimi E, et al. Causes and associations of amblyopia in a population-based sample of 6-year-old Australian children. Arch Ophthalmol. 2006;124:878-884.

15.  Matsuo T, Matsuo C. Comparison of prevalence rates of strabismus and amblyopia in Japanese elementary school children between the years 2003 and 2005. Acta Med Okayama. 2007;61:329-334.

16.  Jamali P, Fotouhi A, Hashemi H, et al. Refractive errors and amblyopia in children entering school: Shahrood, Iran. Optom Vis Sci. 2009;86:364-369.

17.  Donnelly UM, Stewart NM, Hollinger M. Prevalence and outcomes of childhood visual disorders. Ophthalmic Epidemiol. 2005;12:243-250.

18.  Rahi JS, Logan S, Borja MC, et al. Prediction of improved vision in the amblyopic eye after visual loss in the non-amblyopic eye. Lancet. 2002;360:621-622.

19.  Wilson ME. Adult amblyopia reversed by contralateral cataract formation. J Pediatr Ophthalmol Strabismus. 1992;29:100-102.

20.  Larsson EK, Rydberg AC, Holmstrom GE. A population-based study on the visual outcome in 10-year-old preterm and full-term children. Arch Ophthalmol. 2005;123:825-832.

21.  O'Connor AR, Wilson CM, Fielder AR. Ophthalmological problems associated with preterm birth. Eye. 2007;21:1254-1260.

22.  Shah S, Torner J, Mehta A. Prevalence of amblyogenic risk factors in siblings of patients with accommodative esotropia. J AAPOS. 2008;12:487-489.

23.  Abrahamsson M, Magnusson G, Sjostrand J. Inheritance of strabismus and the gain of using heredity to determine populations at risk of developing strabismus. Acta Ophthalmol Scand. 1999;77:653-657.

24.  American Academy of Ophthalmology. Preferred practice pattern: pediatric eye evaluations. San Francisco, CA: American Academy of Ophthalmology; 2012.

25.  Sondhi N, Archer SM, Helveston EM. Development of normal ocular alignment. J Pediatr Ophthalmol Strabismus. 1988;25:210-211.

26.  Chung W, Hong S, Lee JB, et al. Pattern visual evoked potential as a predictor of occlusion therapy for amblyopia. Korean J Ophthalmol. 2008;22:251-254.

27.  Ridder WH 3rd, Rouse MW. Predicting potential acuities in amblyopes: predicting post-therapy acuity in amblyopes. Doc Ophthalmol. 2007;114:135-145.

28.  Powell C, Hatt SR. Vision screening for amblyopia in childhood. Cochrane Database Syst Rev. 2009;(3):CD005020.

29.  Chou R, Dana T, Bougatsos C. Screening for visual impairment in children ages 1-5 years: systematic review to update the 2004 U.S. Preventive Services Task Force Recommendation. Rockville, MD: Agency for Healthcare Research and Quality (US); 2011: 11-05151-EF-1.

30.  Eibschitz-Tsimhoni M, Friedman T, Naor J, et al. Early screening for amblyogenic risk factors lowers the prevalence and severity of amblyopia. J AAPOS. 2000;4:194-199.

31.  Donahue SP, Arthur B, Neely DE, et al. Guidelines for automated preschool vision screening: a 10-year, evidence-based update. J AAPOS. 2013;17:4-8.

32.  Chen PL, Chen JT, Tai MC, et al. Anisometropic amblyopia treated with spectacle correction alone: possible factors predicting success and time to start patching. Am J Ophthalmol. 2007;143:54-60.

33.  Cotter SA, Edwards AR, Wallace DK, et al. Treatment of anisometropic amblyopia in children with refractive correction. Ophthalmology. 2006;113:895-903.

34.  Wallace DK, Chandler DL, Beck RW, et al. Pediatric Eye Disease Investigator Group. Treatment of bilateral refractive amblyopia in children three to less than 10 years of age. Am J Ophthalmol. 2007;144:487-496.

35.  Pediatric Eye Disease Investigator Group. A randomized trial of atropine vs. patching for treatment of moderate amblyopia in children. Arch Ophthalmol. 2002;120:268-278.

36.  Repka MX, Beck RW, Holmes JM, et al. Pediatric Eye Disease Investigator Group. A randomized trial of patching regimens for treatment of moderate amblyopia in children. Arch Ophthalmol. 2003;121:603-611.

37.  Wallace DK, Edwards AR, Cotter SA, et al. A randomized trial to evaluate 2 hours of daily patching for strabismic and anisometropic amblyopia in children. Ophthalmology. 2006;113:904-912.

38.  Stewart CE, Stephens DA, Fielder AR, et al. Objectively monitored patching regimens for treatment of amblyopia: randomised trial. BMJ. 2007;335:707.

39.  Menon V, Shailesh G, Sharma P, et al. Clinical trial of patching versus atropine penalization for the treatment of anisometropic amblyopia in older children. J AAPOS. 2008;12:493-497.

40.  Holmes JM, Kraker RT, Beck RW, et al. Pediatric Eye Disease Investigator Group. A randomized trial of prescribed patching regimens for treatment of severe amblyopia in children. Ophthalmology. 2003;110:2075-2087.

41.  Repka MX, Kraker RT, Beck RW, et al. A randomized trial of atropine vs patching for treatment of moderate amblyopia: follow-up at age 10 years. Arch Ophthalmol. 2008;126:1039-1044.

42.  Scheiman MM, Hertle RW, Kraker RT, et al. Pediatric Eye Disease Investigator Group. Patching vs atropine to treat amblyopia in children aged 7 to 12 years: a randomized trial. Arch Ophthalmol. 2008;126:1634-1642.

43.  Holmes JM, Lazar EL, Melia BM, et al. Pediatric Eye Disease Investigator Group. Effect of age on response to amblyopia treatment in children. Arch Ophthalmol. 2011;129:1451-1457.

44.  Maconachie GD, Farooq S, Bush G, et al. Association between adherence to glasses wearing during amblyopia treatment and improvement in visual acuity. J AMA Ophthalmol. 2016 Oct 13 [Epub ahead of print].

45.  Awan M, Proudlock FA, Gottlob I. A randomized controlled trial of unilateral strabismic and mixed amblyopia using occlusion dose monitors to record compliance. Invest Ophthalmol Vis Sci. 2005;46:1435-1439.

46.  Stewart CE, Moseley MJ, Stephens DA, et al. Treatment dose-response in amblyopia therapy: the Monitored Occlusion Treatment of Amblyopia Study (MOTAS). Invest Ophthalmol Vis Sci. 2004;45:3048-3054.

47.  Wallace DK, Lazar EL, Holmes JM, et al; Pediatric Eye Disease Investigator Group. A randomized trial of increasing patching for amblyopia. Ophthalmology. 2013;120:2270-2277.

48.  Tjiam AM, Holtslag G, Van Minderhout HM, et al. Randomised comparison of three tools for improving compliance with occlusion therapy: an educational cartoon story, a reward calendar, and an information leaflet for parents. Graefes Arch Clin Exp Ophthalmol. 2013;251:321-329.

49.  Pradeep A, Proudlock FA, Awan M, et al. An educational intervention to improve adherence to high-dosage patching regimen for amblyopia: a randomised controlled trial. Br J Ophthalmol. 2014;98:865-870.

50.  Pediatric Eye Disease Investigator Group. Pharmacological plus optical penalization treatment for amblyopia: results of a randomized trial. Arch Ophthalmol. 2009;127:22-30.

51.  Tejedor J, Ogallar C. Comparative efficacy of penalization methods in moderate to mild amblyopia. Am J Ophthalmol. 2008;145:562-569.

52.  Repka MX, Kraker RT, Beck RW, et al. Pediatric Eye Disease Investigator Group. Treatment of severe amblyopia with weekend atropine: results from two randomized clinical trials. J AAPOS. 2009;13:258-263.

53.  Pediatric Eye Disease Investigator Group. A randomized trial of near versus distance activities while patching for amblyopia in children aged 3 to less than 7 years. Ophthalmology. 2008;115:2071-2078.

54.  Birch EE, Cheng C, Stager DR Jr, et al. The critical period for surgical treatment of dense congenital bilateral cataracts. J AAPOS. 2009;13:67-71.

55.  Birch EE, Stager DR. The critical period for surgical treatment of dense congenital unilateral cataract. Invest Ophthalmol Vis Sci. 1996;37:1532-1538.

56.  Hakim, OM, Gaber El-Hag Y, Samir A. Silicone-eyelid closure to improve vision in deeply amblyopic eyes. J Pediatr Ophthalmol Strabismus. 2010;47:157-162.

57.  Arnold RW, Armitage MD, Limstrom SA. Sutured protective occluder for severe amblyopia. Arch Ophthalmol. 2008;126:891-895.

58.  Scheiman MM, Hertle RW, Beck RW, et al. Pediatric Eye Disease Investigator Group. Randomized trial of treatment of amblyopia in children aged 7 to 17 years. Arch Ophthalmol. 2005;123:437-447.

59.  Hertle RW, Scheiman MM, Beck RW, et al. Pediatric Eye Disease Investigator Group. Stability of visual acuity improvement following discontinuation of amblyopia treatment in children aged 7 to 12 years. Arch Ophthalmol. 2007;125:655-659.

60.  American Optometric Association. Care of the patient with amblyopia. 2004. http://www.aoa.org (last accessed 6 December 2016).

61.  Chen PL, Chen JT, Fu JJ, et al. A pilot study of anisometropic amblyopia improved in adults and children by perceptual learning: an alternative treatment to patching. Ophthalmic Physiol Opt. 2008;28:422-428.

62.  Herbison N, Cobb S, Gregson R, et al. Interactive binocular treatment (I-BiT) for amblyopia: results of a pilot study of 3D shutter glasses system. Eye (Lond). 2013;27:1077-1083.

63.  Herbison N, MacKeith D, Vivian A, et al. Randomised controlled trial of video clips and interactive games to improve vision in children with amblyopia using the I-BiT system. Br J Ophthalmol. 2016 Mar 7 [Epub ahead of print].

64.  Li SL, Jost RM, Morale SE, et al. A binocular iPad treatment for amblyopic children. Eye (Lond). 2014;28:1246-1253.

65.  Tailor V, Bossi M, Bunce C, et al. Binocular versus standard occlusion or blurring treatment for unilateral amblyopia in children aged three to eight years. Cochrane Database Syst Rev. 2015;(8):CD011347.

66.  Gottlob I, Stangler-Zuschrott E. Effect of levodopa on contrast sensitivity and scotomas in human amblyopia. Invest Ophthalmol Vis Sci. 1990;31:776-780.

67.  Gottlob I, Charlier J, Reinecke RD. Visual acuities and scotomas after one week levodopa administration in human amblyopia. Invest Ophthalmol Vis Sci. 1992;33:2722-2728.

68.  Bhartiya P, Sharma P, Biswas NR, et al. Levodopa-carbidopa with occlusion in older children with amblyopia. J AAPOS. 2002;6:368-372.

69.  Pediatric Eye Disease Investigator Group. A randomized trial of levodopa as treatment for residual amblyopia in older children. Ophthalmology. 2015;122:874-881.

70.  Spierer A, Raz J, Benezra O, et al. Treating amblyopia with liquid crystal glasses: a pilot study. Invest Ophthalmol Vis Sci. 2010;51:3395-3398.

71.  Erbağcı I, Okumuş S, Öner V, et al. Using liquid crystal glasses to treat ambyopia in children. J AAPOS. 2015;19:257-259.

72.  Wang J, Neely DE, Galli J, et al. A pilot randomized clinical trial of intermittent occlusion therapy liquid crystal glasses versus traditional patching for treatment of moderate unilateral amblyopia. J AAPOS. 2016;20:326-331.

73.  Fresina M, Dickmann A, Salerni A, et al. Effect of oral CDP-choline on visual function in young amblyopic patients. Graefes Arch Clin Exp Ophthalmol. 2008;246:143-150.

74.  Thompson B, Mansouri B, Koski L, et al. Brain plasticity in the adult: modulation of function in amblyopia with rTMS. Curr Biol. 2008;18:1067-1071.

75.  Lam DS, Zhao J, Chen LJ, et al. Adjunctive effect of acupuncture to refractive correction on anisometropic amblyopia: one-year results of a randomized crossover trial. Ophthalmology. 2011;1501-1511.

76.  Zhao J, Lam DS, Chen LJ, et al. Randomized controlled trial of patching vs acupuncture for anisometropic amblyopia in children aged 7 to 12 years. Arch Opthalmol. 2010;128:1510-1517.

77.  Tychsen L, Hoekel J, Ghasia F, et al. Phakic intraocular lens correction of high ametropia in children with neurobehavioral disorders. J AAPOS. 2008;12:282-289.

78.  Ali A, Packwood E, Lueder G, et al. Unilateral lens extraction for high anisometropic myopia in children and adolescents. J AAPOS. 2007;11:153-158.

79.  Paysse EA, Coats DK, Hussein MA, et al. Long-term outcomes of photorefractive keratectomy for anisometropic amblyopia in children. Ophthalmology. 2006;113:169-176.

80.  Daoud YJ, Hutchinson A, Wallace DK, et al. Refractive surgery in children: treatment options, outcomes, and controversies. Am J Ophthalmol. 2009;147:573-582.

81.  Simons K, Preslan M. Natural history of amblyopia untreated owing to lack of compliance. Br J Ophthalmol. 1999;83:582-587.

82.  Pirouzian A, Ip KC. Anterior chamber phakic intraocular lens implantation in children to treat severe anisometropic myopia and amblyopia: 3-year clinical results. J Cataract Refract Surg. 2010;36:1486-1493.

83.  Alió JL, Wolter NV, Piñero DP, et al. Pediatric refractive surgery and its role in the treatment of amblyopia: meta-analysis of the peer-reviewed literature. J Refract Surg. 2011;27:364-374.

84.  Tommila V, Tarkkanen A. Incidence of loss of vision in the healthy eye in amblyopia. Br J Ophthalmol. 1981;65:575-577.

85.  van Leeuwen R, Eijkemans MJ, Vingerling JR, et al. Risk of bilateral visual impairment in individuals with amblyopia: the Rotterdam study. Br J Ophthalmol. 2007;91:1450-1451.

86.  Wallace DK, Lazar EL, Melia M, et al; Pediatric Eye Disease Investigator Group. Stereoacuity in children with anisometropic amblyopia. J AAPOS. 2011;15:455-461.

87.  Repka MX, Wallace DK, Beck RW, et al. Two-year follow-up of a 6-month randomized trial of atropine vs patching for treatment of moderate amblyopia in children. Arch Ophthalmol. 2005;123:149-157.

88.  American Academy of Ophthalmology. Pediatric ophthalmology/strabismus summary benchmarks - 2016. October 2016. http://one.aao.org/ (last accessed 8 December 2016).

89.  Tims C. Difficulties with patching. In: Taylor D, Hoyt CS, eds. Pediatric ophthalmology and strabismus, 3rd ed. Edinburgh, UK: Elsevier Saunders; 2005:1103-1105.

90.  Loudon SE, Fronius M, Looman CW, et al. Predictors and a remedy for noncompliance with amblyopia therapy in children measured with the occlusion dose monitor. Invest Ophthalmol Vis Sci. 2006;47:4393-4400.

使用此内容应接受我们的免责声明